Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice

被引:9
作者
Wu, Jingyi [1 ]
Jia, Shu [1 ]
Xu, Benghong [2 ]
Yao, Xiaokun [1 ]
Shao, Jingping [1 ]
Yao, Jianzuo [3 ]
Cen, Danwei [1 ]
Yao, Xiaomin [1 ]
机构
[1] Zhejiang Pharmaceut Univ, Fac Pharm, Ningbo, Peoples R China
[2] Shenzhen Ctr Dis Control & Prevent, Shenzhen Key Lab Modern Toxicol, Shenzhen Med Key Discipline Hlth Toxicol, Shengzhen, Guangdong, Peoples R China
[3] Ningbo Univ, Dept Hepatobiliary & Pancreat Surg, Li Huili Hosp, Ningbo, Peoples R China
关键词
bicyclol; NAFLD; NASH; proteomics; multiple pathways;
D O I
10.3389/fphar.2023.1157200
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The pathological progression of non-alcoholic fatty liver disease (NAFLD) is driven by multiple factors, and non-alcoholic steatohepatitis (NASH) represents its progressive form. In our previous studies, we found that bicyclol had beneficial effects on NAFLD/ NASH. Here we aim to investigate the underlying molecular mechanisms of the bicyclol effect on NAFLD/NASH induced by high-fat diet (HFD) feeding.Methods: A mice model of NAFLD/NASH induced by HFD-feeding for 8 weeks was used. As a pretreatment, bicyclol (200 mg/kg) was given to mice by oral gavage twice daily. Hematoxylin and eosin (H&E) stains were processed to evaluate hepatic steatosis, and hepatic fibrous hyperplasia was assessed by Masson staining. Biochemistry analyses were used to measure serum aminotransferase, serum lipids, and lipids in liver tissues. Proteomics and bioinformatics analyses were performed to identify the signaling pathways and target proteins. Data are available via Proteome X change with identifier PXD040233. The real-time RT-PCR and Western blot analyses were performed to verify the proteomics data.Results: Bicyclol had a markedly protective effect against NAFLD/NASH by suppressing the increase of serum aminotransferase, hepatic lipid accumulation and alleviating histopathological changes in liver tissues. Proteomics analyses showed that bicyclol remarkably restored major pathways related to immunological responses and metabolic processes altered by HFD feeding. Consistent with our previous results, bicyclol significantly inhibited inflammation and oxidative stress pathway related indexes (SAA1, GSTM1 and GSTA1). Furthermore, the beneficial effects of bicyclol were closely associated with the signaling pathways of bile acid metabolism (NPC1, SLCOLA4 and UGT1A1), cytochrome P450-mediated metabolism (CYP2C54, CYP3A11 and CYP3A25), biological processes such as metal ion metabolism (Ceruloplasmin and Metallothionein-1), angiogenesis (ALDH1A1) and immunological responses (IFI204 and IFIT3).Discussion: These findings suggested that bicyclol is a potential preventive agent for NAFLD/NASH by targeting multiple mechanisms in future clinical investigations.
引用
收藏
页数:14
相关论文
共 38 条
[1]   TGF-β1 signaling can worsen NAFLD with liver fibrosis backdrop [J].
Ahmed, Hammad ;
Umar, Muhammad Ihtisham ;
Imran, Salman ;
Javaid, Faraza ;
Syed, Shahzada Khurram ;
Riaz, Romana ;
Hassan, Waseem .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2022, 124
[2]   Association Study of SLCO1B3 and ABCC3 Genetic Variants in Gallstone Disease [J].
Banach, Boleslaw ;
Modrzejewski, Andrzej ;
Juzyszyn, Zygmunt ;
Kurzawski, Mateusz ;
Sroczynski, Tomasz ;
Pawlik, Andrzej .
GENES, 2022, 13 (03)
[3]   Macrophage functional diversity in NAFLD - more than inflammation [J].
Barreby, Emelie ;
Chen, Ping ;
Aouadi, Myriam .
NATURE REVIEWS ENDOCRINOLOGY, 2022, 18 (08) :461-472
[4]   Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways [J].
Chen, Yanghao ;
Lin, Wante ;
Zhong, Lingfeng ;
Fang, Zimin ;
Ye, Bozhi ;
Wang, Zhe ;
Chattipakorn, Nipon ;
Huang, Weijian ;
Liang, Guang ;
Wu, Gaojun .
CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (06) :1131-1141
[5]   Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1/VEGF signalling in MCF-7 breast cancer cells [J].
Ciccone, Valerio ;
Terzuoli, Erika ;
Donnini, Sandra ;
Giachetti, Antonio ;
Morbidelli, Lucia ;
Ziche, Marina .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
[6]   Metallothionein 1: A New Spotlight on Inflammatory Diseases [J].
Dai, Hanying ;
Wang, Lu ;
Li, Lingyun ;
Huang, Zhong ;
Ye, Liang .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[7]   HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway [J].
Ding, Jiexia ;
Wu, Lili ;
Zhu, Guoxian ;
Zhu, Jing ;
Luo, Pingping ;
Li, Youming .
MOLECULAR BIOLOGY REPORTS, 2023, 50 (02) :961-970
[9]   Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease [J].
Fu, Yajie ;
Zhou, Yanzhi ;
Shen, Linhu ;
Li, Xuewen ;
Zhang, Haorui ;
Cui, Yeqi ;
Zhang, Ke ;
Li, Weiguo ;
Chen, Wei-Dong ;
Zhao, Shizhen ;
Li, Yunfu ;
Ye, Wenling .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[10]   Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease? [J].
Gehrke, Nadine ;
Schattenberg, Joern M. .
GASTROENTEROLOGY, 2020, 158 (07) :1929-+